From: Factors associated with serum total homocysteine level in type 2 diabetes
Males (n = 196) | Females (n = 84) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Mean ± SE (μmol/l) | Least squares means ± SE (μmol/l) | p valued | p valuee | n | Mean ± SE (μmol/l) | Least squares means ± SE (μmol/l) | p valued | p valuee | |
Treatment | ||||||||||
Diet and exercise | 60 | 11.22 ± 3.26 | 11.57 ± 0.98 b | 0.146 | 0.622 | 23 | 9.69 ± 2.59 | 9.84 ± 0.61 b | 0.700 | 0.862 |
Oral agents | 109 | 12.21 ± 3.76 | 12.17 ± 0.69 b | – | 47 | 9.71 ± 2.26 | 9.97 ± 0.36 b | – | ||
Insulin treatment | 27 | 14.90 ± 17.30 | 14.14 ± 1.41 b | 0.209 | 14 | 11.40 ± 9.53 | 10.26 ± 0.75 b | 0.730 | ||
p for trenda | 0.039 | 0.178 | 0.316 | 0.710 | ||||||
Complication | ||||||||||
Neuropathy (−) | 119 | 12.38 ± 9.05 | 12.74 ± 0.66 b | 61 | 9.50 ± 2.49 | 9.84 ± 0.32 b | ||||
Neuropathy (+) | 77 | 12.15 ± 3.47 | 11.54 ± 0.82 b | 23 | 11.27 ± 7.30 | 10.37 ± 0.52 b | ||||
p for trenda | 0.835 | 0.261 | 0.101 | 0.397 | ||||||
Retinopathy (−) | 151 | 11.99 ± 8.09 | 12.41 ± 0.59 b | 67 | 9.88 ± 4.63 | 9.74 ± 0.30 b | ||||
Retinopathy (+) | 45 | 13.28 ± 3.99 | 11.76 ± 1.13 b | 17 | 10.39 ± 3.35 | 10.92 ± 0.59 b | ||||
p for trenda | 0.307 | 0.623 | 0.671 | 0.080 | ||||||
Nephropathy (−) | 175 | 11.53 ± 3.26 | 11.58 ± 0.53 c | 78 | 9.49 ± 2.62 | 9.46 ± 0.46 c | ||||
Nephropathy(+) | 21 | 18.59 ± 19.75 | 18.08 ± 1.55 c | 6 | 16.45 ± 12.66 | 16.47 ± 1.64 c | ||||
p for trenda | <0.001 | <0.001 | <0.001 | <0.001 |